VERACYTE, INC.·4

Feb 5, 4:49 PM ET

Chambers Rebecca 4

4 · VERACYTE, INC. · Filed Feb 5, 2025

Insider Transaction Report

Form 4
Period: 2025-02-03
Chambers Rebecca
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2025-02-03$43.85/sh527$23,109113,510 total
Footnotes (1)
  • [F1]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 13, 2024.

Documents

1 file
  • 4
    wk-form4_1738792155.xmlPrimary

    FORM 4